By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ivantis, Inc. 

13766 Alton Parkway
Suite 150
Irvine  California  92618  U.S.A.
Phone: 949-600-9650 Fax: 949-600-9651


Medical Device

Start Up

Company News
Ivantis Nabs $25 Million Series C for Hydrus Microstent 1/9/2017 1:18:07 PM
Ivantis, Inc. Completes Enrollment In Pivotal HYDRUS IV Glaucoma Study Of The Hydrus Microstent 4/17/2015 10:44:04 AM
Ivantis, Inc. Announces HYDRUS II Glaucoma Study Met Primary Endpoint In A Randomized Controlled Trial At Two Years 10/21/2014 7:19:05 AM
SoCal's Ivantis, Inc. Reels In Another $25 Million; Increasing Series B Funding To $71 Million 9/23/2014 6:08:47 AM
Ivantis, Inc. Reels In $46.5 Million; Wins FDA Approval to Expand US Pivotal Trial For Novel Glaucoma Device 1/13/2014 8:11:45 AM
Ivantis, Inc. Raises Additional $5 Million From Singapore-Based Global Investor EDBI, Increasing Series B to $32.5 Million 8/20/2013 6:43:52 AM
Ivantis, Inc. Announces 1-Year Results for Novel Glaucoma Treatment 7/18/2013 10:17:51 AM
Ivantis, Inc. Announces Completion of $27 Million Financing for Novel Glaucoma Procedure 1/31/2013 9:01:10 AM
Ivantis, Inc. Enrolls First Patient for U.S. Clinical Study on Glaucoma 3/6/2012 10:57:07 AM
Ivantis, Inc. Scores $17 Million For Glaucoma Treatments 6/27/2011 8:56:29 AM